Unidade de Investigación en Cardioloxía Celular e Molecular
C.C.M.
![Foto de Unidade de Investigación en Cardioloxía Celular e Molecular](/img/grupo.png)
![Foto de Hospital Universitari de Bellvitge](/img/noimage_org.png)
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (57)
2024
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Cardiorenal benefits of finerenone: protecting kidney and heart
Annals of Medicine, Vol. 55, Núm. 1, pp. 502-513
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Journal of Clinical Medicine, Vol. 12, Núm. 8
-
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses
European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202
-
Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
Patient Preference and Adherence, Vol. 17, pp. 839-849
-
The three-noes right-sided infective endocarditis: An unrecognized type of right-sided endocarditis
Medicine, Vol. 102, Núm. 29, pp. e34322
-
Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530
2022
-
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry
European journal of preventive cardiology, Vol. 29, Núm. 6, pp. 859-868
-
Challenges in managing patients with heart failure with reduced ejection fraction
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 1-7
-
Clinical and therapeutic characterization of the ischemic cardiopathy in Spain. Importance of cardiac rehabilitation programs
Medicina Clinica Practica, Vol. 5, Núm. 3
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
-
Therapeutic approach to patients with heart failure with reduced ejection fraction. The role of vericiguat
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 23-29
-
Vericiguat in heart failure: from scientific evidence to clinical practice
Revista Clinica Espanola
-
Vericiguat: VICTORIA trial results
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 15-22
2021
-
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study
Open Forum Infectious Diseases, Vol. 8, Núm. 6